| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5659106 | Gastrointestinal Endoscopy | 2017 | 23 Pages |
Abstract
In patients with BE-HGD/IMC, LNSCT is effective in eliminating dysplasia and intestinal metaplasia. Progression to adenocarcinoma was uncommon, and recurrence of dysplasia was successfully treated in most cases. Long-term surveillance is necessary to detect late recurrence of dysplasia.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Fariha H. MD, MBA, Qingping MPH, Bruce D. MD,